Ameritas Investment Partners, Inc. Durect Corp Transaction History

Ameritas Investment Partners, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.38 - $0.64 $6,639 - $11,182	-17,472 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$1.33 - $2.76 $23,237 - $48,222	17,472 New	17,472 $41,000
Q2 2019 Aug 14, 2019	SELL	$0.51 - $0.86 $6,210 - $10,472	-12,177 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$1.56 - $2.51 $5,460 - $8,785	3,500 Added 40.34%	12,177 $19,000
Q2 2017 Aug 15, 2017	BUY	N/A	8,677	8,677 $14,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $223M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.